Immunologic and Clinical Failure of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus within Two Years of Treatment.

Conclusion: The prevalence of treatment failure was lower with the risk being higher among patients on the AZT-based regimen. On the other hand, the risk of treatment failure was lower among patients who started HAART at baseline CD4 count ≥ 301 and patients who were bedridden during HAART initiation. We recommend further prospective, multicenter cohort studies to be conducted to precisely detect the prevalence of treatment failure using viral load determination in the whole country.
PMID: 32462003 [PubMed - in process]

Source: Biomed Res - May 30, 2020 Category: Research Authors: Asgedom SW, Maru M, Berihun B, Gidey K, Niriayo YL, Atey TM Tags: Biomed Res Int Source Type: research